These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27566771)

  • 1. A Gaussian random field model for similarity-based smoothing in Bayesian disease mapping.
    Baptista H; Mendes JM; MacNab YC; Xavier M; Caldas-de-Almeida J
    Stat Methods Med Res; 2016 Aug; 25(4):1166-84. PubMed ID: 27566771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting Gaussian Markov random fields and Bayesian disease mapping.
    MacNab YC
    Stat Methods Med Res; 2023 Jan; 32(1):207-225. PubMed ID: 36317373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On Gaussian Markov random fields and Bayesian disease mapping.
    MacNab YC
    Stat Methods Med Res; 2011 Feb; 20(1):49-68. PubMed ID: 20547586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial smoothing in Bayesian models: a comparison of weights matrix specifications and their impact on inference.
    Duncan EW; White NM; Mengersen K
    Int J Health Geogr; 2017 Dec; 16(1):47. PubMed ID: 29246157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On identification in Bayesian disease mapping and ecological-spatial regression models.
    MacNab YC
    Stat Methods Med Res; 2014 Apr; 23(2):134-55. PubMed ID: 22573502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skew-elliptical spatial random effect modeling for areal data with application to mapping health utilization rates.
    Nathoo FS; Ghosh P
    Stat Med; 2013 Jan; 32(2):290-306. PubMed ID: 22815268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling for localised spatio-temporal autocorrelation in long-term air pollution and health studies.
    Lee D; Mitchell R
    Stat Methods Med Res; 2014 Dec; 23(6):488-506. PubMed ID: 24648100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression B-spline smoothing in Bayesian disease mapping: with an application to patient safety surveillance.
    MacNab YC; Gustafson P
    Stat Med; 2007 Oct; 26(24):4455-74. PubMed ID: 17357989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling categorical covariates in Bayesian disease mapping by partition structures.
    Giudici P; Knorr-Held L; Rasser G
    Stat Med; 2000 Sep 15-30; 19(17-18):2579-93. PubMed ID: 10960873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bayesian analysis for spatial processes with application to disease mapping.
    Bell BS; Broemeling LD
    Stat Med; 2000 Apr; 19(7):957-74. PubMed ID: 10750062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of conditional autoregressive models used in Bayesian disease mapping.
    Lee D
    Spat Spatiotemporal Epidemiol; 2011 Jun; 2(2):79-89. PubMed ID: 22749587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling spatial disease rates using maximum likelihood.
    Leroux BG
    Stat Med; 2000 Sep 15-30; 19(17-18):2321-32. PubMed ID: 10960856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of mixture models for identifying high risks in disease mapping.
    Militino AF; Ugarte MD; Dean CB
    Stat Med; 2001 Jul; 20(13):2035-49. PubMed ID: 11427958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pointless spatial modeling.
    Wilson K; Wakefield J
    Biostatistics; 2020 Apr; 21(2):e17-e32. PubMed ID: 30202860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian spatiotemporal model of fMRI data.
    Quirós A; Diez RM; Gamerman D
    Neuroimage; 2010 Jan; 49(1):442-56. PubMed ID: 19646535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of spatial scales and spatial smoothing on the outcome of bayesian spatial model.
    Kang SY; McGree J; Mengersen K
    PLoS One; 2013; 8(10):e75957. PubMed ID: 24146799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian estimation of multivariate Gaussian Markov random fields with constraint.
    MacNab YC
    Stat Med; 2020 Dec; 39(30):4767-4788. PubMed ID: 32935375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approximate cross-validatory predictive checks in disease mapping models.
    Marshall EC; Spiegelhalter DJ
    Stat Med; 2003 May; 22(10):1649-60. PubMed ID: 12720302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intuitive Bayesian spatial model for disease mapping that accounts for scaling.
    Riebler A; Sørbye SH; Simpson D; Rue H
    Stat Methods Med Res; 2016 Aug; 25(4):1145-65. PubMed ID: 27566770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrete versus continuous domain models for disease mapping.
    Konstantinoudis G; Schuhmacher D; Rue H; Spycher BD
    Spat Spatiotemporal Epidemiol; 2020 Feb; 32():100319. PubMed ID: 32007284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.